Personal information

No personal information available

Activities

Collapse all

Works (16)

Effectiveness of lumacaftor/ivacaftor initiation in children with cystic fibrosis aged 2 through 5 years on disease progression: Interim results from an ongoing registry-based study

Journal of Cystic Fibrosis
2024-02 | Journal article
DOI: 10.1016/j.jcf.2024.02.004
Part of ISSN: 1569-1993
Contributors: claire kim; Mark Higgins; Lingyun Liu; Nataliya Volkova; Anna Zolin; Lutz Naehrlich; Pfleger (AT) Andreas; Lammertijn (BE) Elise; Tješić-Drinković (HR) Duška; Dřevínek (CZ) Pavel et al.
Source: Self-asserted source
Domenique Zomer

Optimization of performance of Dutch newborn screening for cystic fibrosis

Journal of Cystic Fibrosis
2024-01 | Journal article
DOI: 10.1016/j.jcf.2023.09.001
Contributors: MJ Bouva; JE Dankert-Roelse; CPB van der Ploeg; RK Verschoof-Puite; DD Zomer-van Ommen; JJP Gille; BS Jakobs; MLA Heijnen; KM de Winter-de Groot
Source: check_circle
Crossref

Development and validation of a novel personalized electronic patient-reported outcome measure to assess quality of life (Q-LIFE): a prospective observational study in people with Cystic Fibrosis.

EClinicalMedicine
2023-07-27 | Journal article
DOI: 10.1016/j.eclinm.2023.102116
PMID: 37554124
Contributors: Muilwijk D; van Paridon TJ; van der Heijden DC; Faber-Bisschop BM; Zomer-van Ommen DD; Heijerman HGM; van der Ent CK; Domenique Zomer
Source: Self-asserted source
Domenique Zomer

Epidemiology and management of nontuberculous mycobacterial disease in people with cystic fibrosis, the Netherlands

Journal of Cystic Fibrosis
2023-03 | Journal article
DOI: 10.1016/j.jcf.2022.10.009
Contributors: Domenique Zomer; Jakko van Ingen; Regina Hofland; O.W. Akkerman; J. Altenburg; M. Bakker; M.A.G.E. Bannier; L.H. Conemans; V.A.M. Gulmans; H.G.M. Heijerman et al.
Source: check_circle
Crossref

Long-term effectiveness of dual CFTR modulator treatment of cystic fibrosis.

ERJ open research
2022-10 | Journal article
DOI: 10.1183/23120541.00204-2022
PMID: 36382237
PMC: PMC9661249
Contributors: Muilwijk D; Zomer-van Ommen DD; Gulmans VAM; Eijkemans MJC; van der Ent CK; Dutch Cystic Fibrosis Registry (NCFR) Steering Group:
Source: Self-asserted source
Domenique Zomer via Europe PubMed Central

Forskolin-induced organoid swelling is associated with long-term cystic fibrosis disease progression.

The European respiratory journal
2022-08-18 | Journal article
DOI: 10.1183/13993003.00508-2021
PMID: 35086832
PMC: PMC9386333
Contributors: Domenique Zomer
Source: Self-asserted source
Domenique Zomer

Development and outcomes of a patient driven cystic fibrosis quality of care improvement project.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
2022-07-13 | Journal article
DOI: 10.1016/j.jcf.2022.07.004
PMID: 35842291
Contributors: Domenique Zomer
Source: Self-asserted source
Domenique Zomer
grade
Preferred source (of 2)‎

Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
2021-04 | Journal article
DOI: 10.1016/j.jcf.2021.03.017
PMID: 34016559
PMC: PMC8053246
Contributors: Naehrlich L; Orenti A; Dunlevy F; Kasmi I; Harutyunyan S; Pfleger A; Keegan S; Daneau G; Petrova G; Tješić-Drinković D et al.
Source: Self-asserted source
Domenique Zomer via Europe PubMed Central

Forskolin-induced swelling of intestinal organoids predicts long-term cystic fibrosis disease progression

2021-02 | Preprint
DOI: 10.1101/2021.02.01.21250609
PPR: PPR277575
Contributors: Muilwijk D; de Poel E; van Mourik P; Suen S; Vonk A; Brunsveld J; Kruisselbrink E; Oppelaar H; Hagemeijer M; Berkers G et al.
Source: Self-asserted source
Domenique Zomer via Europe PubMed Central

Long-term expanding human airway organoids for disease modeling.

The EMBO journal
2019-01-14 | Journal article
DOI: 10.15252/embj.2018100300
PMID: 30643021
PMC: PMC6376275
Contributors: Domenique Zomer
Source: Self-asserted source
Domenique Zomer

Long-term expanding human airway organoids for disease modelling

2018-05 | Preprint
DOI: 10.1101/318444
PPR: PPR13119
Contributors: Sachs N; Zomer-van Ommen DD; Papaspyropoulos A; Heo I; Böttinger L; Klay D; Weeber F; Huelsz-Prince G; Iakobachvili N; Viveen MC et al.
Source: Self-asserted source
Domenique Zomer via Europe PubMed Central

Comparison of ex vivo and in vitro intestinal cystic fibrosis models to measure CFTR-dependent ion channel activity.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
2018-03-13 | Journal article
DOI: 10.1016/j.jcf.2018.02.007
PMID: 29544685
Contributors: Domenique Zomer
Source: Self-asserted source
Domenique Zomer

β2-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosis.

The European respiratory journal
2016-07-28 | Journal article
DOI: 10.1183/13993003.01661-2015
PMID: 27471203
Contributors: Domenique Zomer
Source: Self-asserted source
Domenique Zomer

Functional Characterization of Cholera Toxin Inhibitors Using Human Intestinal Organoids.

Journal of medicinal chemistry
2016-07-07 | Journal article
DOI: 10.1021/acs.jmedchem.6b00770
PMID: 27347611
Contributors: Domenique Zomer
Source: Self-asserted source
Domenique Zomer

An inducible mouse model for microvillus inclusion disease reveals a role for myosin Vb in apical and basolateral trafficking.

Proceedings of the National Academy of Sciences of the United States of America
2015-09-21 | Journal article
DOI: 10.1073/pnas.1516672112
PMID: 26392529
PMC: PMC4603458
Contributors: Domenique Zomer
Source: Self-asserted source
Domenique Zomer

Limited premature termination codon suppression by read-through agents in cystic fibrosis intestinal organoids.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
2015-08-05 | Journal article
DOI: 10.1016/j.jcf.2015.07.007
PMID: 26255232
Contributors: Domenique Zomer
Source: Self-asserted source
Domenique Zomer
How many people are using ORCID?